All updated as on -
The Lancet Market Size was estimated to be worth USD 1.20 billion in 2022 and is anticipated to increase from USD 1.39 billion in 2023 to USD 2.60 billion by 2030, with a predicted CAGR of 11.50% over the forecast period (2023 - 2030). The primary market drivers boosting market growth include the rising prevalence of diabetes in senior persons, children developing diabetes, and the rising incidences of infectious and non-contagious infections.
A blood lancet is a surgical tool with a blade that has two edges, much like a scalpel. Blood samples are obtained by puncturing the skin with a blade in order to diagnose conditions like diabetes, hyperlipidemia, and dyslipidemia. These lancets are widely used by diabetic individuals to check their blood glucose levels. An inexpensive medical tool called a blood lancet is used to take capillary blood samples. Blood lancets are additionally used to validate a person's blood group at home, in clinics, and in pathology labs.
An increase in the prevalence of chronic diseases like diabetes, hyperlipidemia, and dyslipidemia as well as a rise in the popularity of home care diagnostics are the main drivers fueling the growth of the blood lancets market. The rising use of disposable blood lancets for painless blood sugar, hemoglobin, fat level, and other essential blood component diagnosis is another factor driving market expansion. The market for blood lancets is expanding as a result of disposable lancets' reduced risk of infection and blood transfusion. The industry is anticipated to be driven by rising government investment and technological developments in diabetes control. Faster product approvals and the introduction of technologically improved items are anticipated to drive market expansion during the forecast period.
The lancets market is expected to have slow growth due to unfavorable reimbursement rules and the hazards of blood transfusion. This Lancets market report details recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of local and domestic market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansion, and
Due to their large patient populations and rising disposable incomes, emerging markets like India, China, and nations in Southeast Asia present attractive potential for the lancets business. These nations currently have a low lancet penetration rate. This is a result of these countries' low levels of product adoption and general ignorance. Another obstacle preventing the widespread use of lancets in these nations is a lack of funding. These obstacles can be successfully overcome and assist boost the penetration of lancets in underdeveloped nations through the introduction of cost-effective goods and extensive advertising and awareness initiatives.
The medical community has made an effort to address them, which have been a serious problem. The underlying reason of this can be linked to an unhealthy lifestyle, which can lead to an increase in blood glucose levels and the development of diabetes. For instance, the International Diabetes Federation estimates that there are currently 463 million people worldwide who have diabetes, and that number is predicted to increase to 700 million by the year 2050. Additionally, rising rates of diabetes in children and seniors, modern technology, and home care systems all contribute to the lancet's market expansion. The government's initiatives to raise diabetes awareness, heel-stick screening tests, patients who have been severely burned, and tests on infants are some of the additional reasons that will propel market expansion in the upcoming years.
Report Coverage
Global Lancets research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Lancets report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Lancets competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Lancets market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Lancets market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Lancets market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
BD, F. Hoffmann-La Roche Ltd, Ypsomed AG, B. Braun Melsungen AG, Terumo Medical Corporation, Owen Mumford Ltd, HTL-STREFA S.A., ARKRAY, Inc, Sarstedt AG & Co. KG, SteriLance Medical (Suzhou) Inc., Medline Industries, Inc., Intrinsyk, LLC., Nipro., Improve Medical, LifeScan, Inc., AgaMatrix, Smiths Group PLC, Becton Dickinson and Company (US), Abbott Laboratories (US), Greiner Bio-One International GmbH (US), and others
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Lancets market based on the below-mentioned segments:
Global Lancets Market, By Type
Safety Lancet
Push Button Safety Lancet
Pressure Activated Safety Lancet
Side Button Safety Lancet
Personal Lancet
Global Lancets Market, By End User
Hospitals & Clinics
Diagnostic Centers and Pathology Laboratories
Home Diagnostics
Research and Academic Laboratories
Global Lancets market, Regional Analysis
A blood lancet is a surgical tool with a blade that has two edges, much like a scalpel. Blood samples are obtained by puncturing the skin with a blade in order to diagnose conditions like diabetes, hyperlipidemia, and dyslipidemia. These lancets are widely used by diabetic individuals to check their blood glucose levels. An inexpensive medical tool called a blood lancet is used to take capillary blood samples. Blood lancets are additionally used to validate a person's blood group at home, in clinics, and in pathology labs.
An increase in the prevalence of chronic diseases like diabetes, hyperlipidemia, and dyslipidemia as well as a rise in the popularity of home care diagnostics are the main drivers fueling the growth of the blood lancets market. The rising use of disposable blood lancets for painless blood sugar, hemoglobin, fat level, and other essential blood component diagnosis is another factor driving market expansion. The market for blood lancets is expanding as a result of disposable lancets' reduced risk of infection and blood transfusion. The industry is anticipated to be driven by rising government investment and technological developments in diabetes control. Faster product approvals and the introduction of technologically improved items are anticipated to drive market expansion during the forecast period.
The lancets market is expected to have slow growth due to unfavorable reimbursement rules and the hazards of blood transfusion. This Lancets market report details recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of local and domestic market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansion, and
Due to their large patient populations and rising disposable incomes, emerging markets like India, China, and nations in Southeast Asia present attractive potential for the lancets business. These nations currently have a low lancet penetration rate. This is a result of these countries' low levels of product adoption and general ignorance. Another obstacle preventing the widespread use of lancets in these nations is a lack of funding. These obstacles can be successfully overcome and assist boost the penetration of lancets in underdeveloped nations through the introduction of cost-effective goods and extensive advertising and awareness initiatives.
The medical community has made an effort to address them, which have been a serious problem. The underlying reason of this can be linked to an unhealthy lifestyle, which can lead to an increase in blood glucose levels and the development of diabetes. For instance, the International Diabetes Federation estimates that there are currently 463 million people worldwide who have diabetes, and that number is predicted to increase to 700 million by the year 2050. Additionally, rising rates of diabetes in children and seniors, modern technology, and home care systems all contribute to the lancet's market expansion. The government's initiatives to raise diabetes awareness, heel-stick screening tests, patients who have been severely burned, and tests on infants are some of the additional reasons that will propel market expansion in the upcoming years.
Report Coverage
Global Lancets research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Lancets report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Lancets competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Lancets market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | BD, F. Hoffmann-La Roche Ltd, Ypsomed AG, B. Braun Melsungen AG, Terumo Medical Corporation, Owen Mumford Ltd, HTL-STREFA S.A., ARKRAY, Inc, Sarstedt AG & Co. KG, SteriLance Medical (Suzhou) Inc., Medline Industries, Inc., Intrinsyk, LLC., Nipro., Improve Medical, LifeScan, Inc., AgaMatrix, Smiths Group PLC, Becton Dickinson and Company (US), Abbott Laboratories (US), Greiner Bio-One International GmbH (US), and others |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Lancets Market from 2021 to 2030.
- Market Forecast for Lancets Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Lancets competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Lancets
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Lancets market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Lancets market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
BD, F. Hoffmann-La Roche Ltd, Ypsomed AG, B. Braun Melsungen AG, Terumo Medical Corporation, Owen Mumford Ltd, HTL-STREFA S.A., ARKRAY, Inc, Sarstedt AG & Co. KG, SteriLance Medical (Suzhou) Inc., Medline Industries, Inc., Intrinsyk, LLC., Nipro., Improve Medical, LifeScan, Inc., AgaMatrix, Smiths Group PLC, Becton Dickinson and Company (US), Abbott Laboratories (US), Greiner Bio-One International GmbH (US), and others
Primary Target Market
- Market Players of Lancets
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Lancets market based on the below-mentioned segments:
Global Lancets Market, By Type
Safety Lancet
Push Button Safety Lancet
Pressure Activated Safety Lancet
Side Button Safety Lancet
Personal Lancet
Global Lancets Market, By End User
Hospitals & Clinics
Diagnostic Centers and Pathology Laboratories
Home Diagnostics
Research and Academic Laboratories
Global Lancets market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive lancets market market research and competitor analysis for your business to help you develop more profound insights into the lancets market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the lancets market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.